Alkem tests consolidation by acquiring a 99.61% stake in Enzene Biosciences via a Rs 299.99 crore rights issue, reinforcing control and funding for capex and working capital.
AI Assistant
Alkem Laboratories Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.